Myocardial infarction-induced microRNA-enriched exosomes contribute to cardiac Nrf2 dysregulation in chronic heart failure

Abstract

The imbalance between the synthesis of reactive oxygen species and their elimination by antioxidant defense systems results in macromolecular damage and disruption of cellular redox signaling, affecting cardiac structure and function, thus contributing to contractile dysfunction, myocardial hypertrophy, and fibrosis in chronic heart failure [chronic heart failure (CHF)]. The Kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 (Nrf2) pathway is an important antioxidant defense mechanism and is closely associated with oxidative stress-mediated cardiac remodeling in CHF. In the present study, we investigated the regulation of myocardial Nrf2 in the postmyocardial infarction (post-MI) state. Six weeks post-MI, Nrf2 protein was downregulated in the heart, resulting in a decrease of Nrf2-targeted antioxidant enzymes, whereas paradoxically the transcription of Nrf2 was increased, suggesting that translational inhibition of Nrf2 may contribute to the dysregulation in CHF. We therefore hypothesized that microRNAs may be involved in the translational repression of Nrf2 mRNA in the setting of CHF. Using quantitative real-time PCR analysis, we found that three microRNAs, including microRNA-27a, microRNA-28-3p, and microRNA-34a, were highly expressed in the left ventricle of infarcted hearts compared with other organs. Furthermore, in vitro analysis revealed that cultured cardiac myocytes and fibroblasts expressed these three microRNAs in response to TNF-α stimulation. These microRNAs were preferentially incorporated into exosomes and secreted into the extracellular space in which microRNA-enriched exosomes mediated intercellular communication and Nrf2 dysregulation. Taken together, these results suggest that increased local microRNAs induced by MI may contribute to oxidative stress by the inhibition of Nrf2 translation in CHF. NEW & NOTEWORTHY The results of this work provide a novel mechanism mediated by microRNA-enriched exosomes, contributing to the nuclear factor erythroid 2-related factor 2 dysregulation and subsequent oxidative stress. Importantly, these new findings will provide a promising strategy to improve the therapeutic efficacy through targeting nuclear factor erythroid 2-related factor 2-related microRNAs in the chronic heart failure state, which show potentially clinical applications.

Cancer Extracellular Vesicles: Next-Generation Diagnostic and Drug Delivery Nanotools

“…Besides their physiological role, EEVs were depicted as a Trojan horse in neurodegenerative processes due to their capability to transfer "toxic" cargos from unhealthy to normal neurons [69,70]. Recently, it was demonstrated that EEVs are involved in a wide range of cardiovascular physiological and pathological processes, with beneficial or pathological activity [71,72]. In this review, we discuss the EEVs' role in cancer.…”

Myocardial cell-to-cell communication via microRNAs

“…More recently, Tian et al. [ 52 ] investigated the effect of tumor necrosis factor (TNFα)-activated FB-derived exosomes on CMs. Although miR-27, miR-28 and miR-34 are more abundant in the exosomes from each cell type following TNFα stimulation, their endogenous expression unaltered in the mother cells, suggesting a selective loading of these miRNAs into exosomes as a cellular response to a pathological stimulus.…”

Exosomal miRNAs as potential biomarkers for acute myocardial infarction

“…In addition, the expression of exosomal miRNA‐3,656 was related to the LVEF in our research, which indicated that the decreased levels of miR‐3,656 might cause decreased systolic function of the heart after AMI. A recent study reported that myocardial infarction‐induced miRNA‐enriched exosomes (miR‐27a, miR‐28‐3p, and miR‐34a) contribute to cardiac nuclear factor erythroid 2‐related factor 2 (Nrf2) dysregulation and subsequent oxidative stress, which affects cardiac structure and contractile dysfunction, leading to myocardial hypertrophy and fibrosis in chronic heart failure . Therefore, targeting these exosomal miRNAs may be a promising strategy to improve the state of heart failure, among other potential clinical applications.…”